Search Results - "Lima, Marcos J. G."

DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant by Dillon, Laura W, Gui, Gege, Page, Kristin M, Ravindra, Niveditha, Wong, Zoë C, Andrew, Georgia, Mukherjee, Devdeep, Zeger, Scott L, El Chaer, Firas, Spellman, Stephen, Howard, Alan, Chen, Karen, Auletta, Jeffery, Devine, Steven M, Jimenez Jimenez, Antonio Martin, De Lima, Marcos J. G, Litzow, Mark R, Kebriaei, Partow, Saber, Wael, Weisdorf, Daniel J, Hourigan, Christopher S

“…IMPORTANCE: Preventing relapse for adults with acute myeloid leukemia (AML) in first remission is the most common indication for allogeneic hematopoietic cell…”
Get full text

Organ sparing of linac‐based targeted marrow irradiation over total body irradiation by Warrell, Gregory R., Colussi, Valdir C., Swanson, Wayne L., Caimi, Paolo F., Mansur, David B., Lima, Marcos J. G., Pereira, Gisele C.

“…Purpose Targeted marrow irradiation (TMI) is an alternative conditioning regimen to total body irradiation (TBI) before bone marrow transplantation in…”
Get full text

Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome by Butt, Omar H, Zhou, Alice Y, Caimi, Paolo F, Luckett, Patrick H, Wisch, Julie K, Derenoncourt, Paul-Robert, Lee, Kenneth, Wu, Gregory F, de Lima, Marcos J G, Campian, Jian L, Frank, Matthew J, DiPersio, John F, Ghobadi, Armin, Ances, Beau M

“…Determining whether neurofilament light chain (NfL) elevations in patients who develop immune effector cell-associated neurotoxicity syndrome (ICANS) occur…”
Get more information

Dual institution experience of nodal marginal zone lymphoma reveals excellent long‐term outcomes in the rituximab era by Starr, Adam G., Caimi, Paolo F., Fu, PingFu, Massoud, Mira R., Meyerson, Howard, Hsi, Eric D., Mansur, David B., Cherian, Sheen, Cooper, Brenda W., De Lima, Marcos J. G., Lazarus, Hillard M., Gerson, Stanton L., Jagadeesh, Deepa, Smith, Mitchell R., Dean, Robert M., Pohlman, Brad L., Hill, Brian T., William, Basem M.

“…Summary Nodal marginal zone lymphoma (NMZL) is a rare non‐Hodgkin lymphoma that arises from mature B‐cells. We delineate outcomes, prognostic factors and…”
Get full text

Dual institution experience of extranodal marginal zone lymphoma reveals excellent long‐term outcomes by Starr, Adam G., Caimi, Paolo F., Fu, PingFu, Massoud, Mira R., Meyerson, Howard, Hsi, Eric D., Mansur, David B., Cherian, Sheen, Singh, Arun D., Cooper, Brenda W., De Lima, Marcos J.G., Lazarus, Hillard M., Gerson, Stanton L., Jagadeesh, Deepa, Smith, Mitchell R., Dean, Robert M., Pohlman, Brad L., Hill, Brian T., William, Basem M.

“…Summary Extranodal marginal zone lymphoma (EMZL) is a B‐cell lymphoma arising from mucosa‐associated lymphoid tissue (MALT). The disease characteristics,…”
Get full text

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia by Gui, Gege, Ravindra, Niveditha, Hegde, Pranay S., Andrew, Georgia, Mukherjee, Devdeep, Wong, Zoë, Auletta, Jeffery J., El Chaer, Firas, Chen, Evan C., Chen, Yi-Bin, Corner, Adam, Devine, Steven M., Iyer, Sunil G., Jimenez Jimenez, Antonio Martin, De Lima, Marcos J. G., Litzow, Mark R., Kebriaei, Partow, Saber, Wael, Spellman, Stephen R., Zeger, Scott L., Page, Kristin M., Dillon, Laura W., Hourigan, Christopher S.

“…Abstract Measurable residual disease (MRD) in adults with acute myeloid leukemia (AML) in complete remission is an important prognostic marker, but detection…”
Get full text

Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia by Gui, Gege, Ravindra, Niveditha, Hegde, Pranay S, Andrew, Georgia, Mukherjee, Devdeep, Wong, Zoë, Auletta, Jeffery J, El Chaer, Firas, Chen, Evan C, Chen, Yi-Bin, Corner, Adam, Devine, Steven M, Iyer, Sunil G, Jimenez Jimenez, Antonio Martin, De Lima, Marcos J G, Litzow, Mark R, Kebriaei, Partow, Saber, Wael, Spellman, Stephen R, Zeger, Scott L, Page, Kristin M, Dillon, Laura W, Hourigan, Christopher S

“…Routine genetic profiling of acute myeloid leukemia (AML) at initial diagnosis has allowed subgroup specific prognostication, drug development, and clinical…”
Get full text

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia by Hegde, Pranay S, Andrew, Georgia, Gui, Gege, Ravindra, Niveditha, Mukherjee, Devdeep, Wong, Zoë C, Auletta, Jeffery J, El Chaer, Firas, Corner, Adam, Devine, Steven M, Jimenez Jimenez, Antonio Martin, De Lima, Marcos J G, Litzow, Mark R, Kebriaei, Partow, Saber, Wael, Spellman, Stephen R, Zeger, Scott L, Page, Kristin M, Dillon, Laura W, Hourigan, Christopher S

Get full text

Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era by Starr, Adam G, Caimi, Paolo F, Fu, PingFu, Massoud, Mira R, Meyerson, Howard, Hsi, Eric D, Mansur, David B, Cherian, Sheen, Cooper, Brenda W, De Lima, Marcos J G, Lazarus, Hillard M, Gerson, Stanton L, Jagadeesh, Deepa, Smith, Mitchell R, Dean, Robert M, Pohlman, Brad L, Hill, Brian T, William, Basem M

“…Splenic marginal zone lymphoma (SMZL) is a rare non-Hodgkin lymphoma. We sought to identify prognostic factors and define outcomes in a cohort of 64 patients…”
Get more information

Organ sparing of linac‐based targeted marrow irradiation over total body irradiation by Warrell, Gregory R., Colussi, Valdir C., Swanson, Wayne L., Caimi, Paolo F., Mansur, David B., de Lima, Marcos J. G., Pereira, Gisele C.

Get full text